Targeting SARS-CoV-2 Main protease and variants for effective antiviral development
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:1 publications
Grant number: 202109PJT
Grant search
Key facts
Disease
COVID-19Start & end year
20212026Known Financial Commitments (USD)
$679,893.75Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
N/A
Research Location
CanadaLead Research Institution
University of AlbertaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC